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Introduction
The emergence of antimicrobial resistance (AMR) has been 
pointed out as a large threat to the advances that have been 
made in modern human medicine as well as in today’s animal 
health, welfare, and production. It has been estimated that 
AMR will contribute to millions of human deaths per year in 
the world in the coming decades (O’Neill, 2016). Acknowledging 
that the threat is substantial, it has been emphasized that 
the current global estimates of the burden of AMR are not 
that informative. The estimates must be improved based 
on comprehensive population-based surveillance data from 
around the world (de Kraker et al., 2016 ). In the livestock sector, 
the production of animal source foods in low-income countries 
is at a particular risk with an estimated loss of 10% by 2050, if 
the emergence and spread of AMR are not curbed (World Bank 
Group, 2017). Thus, AMR is an issue for medicine as well as 
veterinary medicine that does not respect national borders and 
is, therefore, a true One Health, One World challenge (Robinson 
et al., 2016).
Notably, the development of AMR occurs naturally among 
microbes but is augmented by the use of antimicrobials 
(Holmes et  al., 2016). In order to protect the efficiency of 
antimicrobials, it is thus wise to aim for reduced use and limit 
the use to medically rational use. In this review, four aspects 
of antibiotic use and resistance are discussed: firstly, the 
resistance related to livestock and human health; secondly, the 
access to antibiotics in the livestock sector; thirdly, the use of 
antibiotics in the sector; and finally, the reduction of use and 
livestock productivity.
AMR and Livestock and Human Health
Humans and livestock share several pathogenic as well as 
commensal bacterial species. This means that we may use the 
same antimicrobials, antibiotics in this case as it is about bacteria, 
in medicine and veterinary medicine (Cantas and Suer, 2014; 
WHO, 2017; OIE, 2018a). Hence, the development of resistance 
mechanisms that the use of these antibiotics drive is the same in 
bacteria isolated both from humans and from livestock. In a One 
health perspective, it is thus the resistances to antibiotics that 
are the most relevant kind of AMR. Notably, the World Health 
Organization has produced a list of antibiotics that is critically 
important for humans (WHO, 2017). Thus, several countries have 
established regulations or recommendations related to this list 
for the use of antibiotics in veterinary medicine.
Currently, the livestock sector is a significant contributor 
to the global pool of resistant bacteria in the biota given that 
the sector is the largest user of antibiotics worldwide (Van 
Boeckel et al., 2015). There are several reports on the association 
between resistant bacteria in livestock and humans (for 
review, see Hoelzer et  al., 2017). However, except for cases 
where farmworkers have been infected with resistant bacteria 
from livestock, the importance of the sector as a contributor 
to resistant microbes to the human population as a whole is 
at large not known (Tang et  al., 2017). Even so, for the risk of 
transmission of resistance to humans and for the sake of animal 
health, it is reasonable to reduce the use of antibiotics in the 
livestock sector, where there is an excessive use (e.g., Robinson 
et al., 2016). In support to this, O’Neill (2016) found in a literature 
in the PubMed database that 100 “academic papers” supported 
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limiting antibiotic use in agriculture, 7 against limiting use, and 
36 were neutral. Academic papers were defined as those that 
were exclusively written by academics.
Access to Antibiotics in the Livestock Sector
The access to antibiotics varies a lot for farmers around the 
world and sometimes within a country. Particularly in low-
income countries it is the access to antibiotics, especially 
of good quality, that is the challenge as demonstrated in 
human medicine. (Kelesidis and Falagas, 2015; Laxminarayan 
et  al., 2016). There are, for instance, estimates that suggest 
that substandard and non-registered drugs at a value of 400 
Millions US dollars a year are sold in the livestock sector 
in Africa, which is similar to the official market (Kingsley, 
2015).These antibiotics may be falsely branded or expired, 
thereby containing a lower, or no, active ingredient than 
indicated, or harmful ingredients.
The distribution channels of antibiotics do also vary around 
the world; in many low- and middle-income countries, one 
may buy antibiotics over the counter without a prescription. 
In a survey conducted by the European Commission (EC) in 
70 non-EU countries (Table 1; EC, 2017), it was found that the 
prescription requirement is highest in high-income countries 
and lowest in low-income countries. Anecdotal, it is said that 
in several countries a large, sometimes the major, proportion 
of the income for physicians and veterinarians comes from 
the sales of antibiotics and other pharmaceuticals. In a survey 
conducted by the Federation of Veterinarians in Europe based 
on self-reporting, it was found that in some large European 
countries, between 24% and 20% of the revenues come from sales 
of medicines, whereas in other countries, it is about 1% to 3 % 
(FVE, 2015). These differences may attributable to the difference 
in legalization, general health status, disease spectrum, or 
different medical approaches to animal health issues or other 
factors. Remarkably, within the relatively economically and 
legislative homogenous Europe, there are immense differences 
between countries in the use of antibiotics in the livestock 
sector, with the lowest use in the Nordic countries and highest 
in the Southern countries (see Figure 1; ESVAC, 2019). Possibly, 
the reasons for these differences are similar to those for 
the differences in revenues from the sales of antibiotics as 
described above.
The trade over the internet is a new, challenging, and 
unregulated source of antibiotics. However, solid reports on 
the volumes, or importance, of this trade is currently not at 
hand.
Use of Antibiotics in the Livestock Sector
It is widely acknowledged that there is a positive relationship 
between the amount of used antibiotics in the livestock sector 
and the development of antibiotic resistance (Bengtsson and 
Wierup, 2006; Chantziaras et al., 2014; Tang et al., 2019). Thus, 
to protect the efficiency of antibiotics in livestock farming for 
curing diseases and maintain productivity and animal welfare, it 
is crucial to apply a restrictive approach and only use antibiotics 
when exclusively needed.
One of the large differences between the use of antibiotics 
in the livestock sector and human health sector is that in 
the former there is a large prophylactic use and a use of 
antibiotics as “growth promoters.” There have been estimates 
of the global use of antimicrobials in the livestock sector (Van 
Boeckel et al., 2015, 2017), but proper data are in general weak 
when looking for data in low- and middle-income countries 
(Cuong et al., 2018). Also, comparisons between OECD countries 
are challenging as different measures are used. Within the 
European Union, there is a harmonized system in which the 
use is equalized by using a population correction unit (ESVAC, 
2019). The World Animal Health Organisation, OIE, has in 
their annual reports on the use of antimicrobials in animals, 
progressed their data collection methodology (Góchez et  al., 
2019). However, the data in these reports are aggregated on 
regional levels in the world.
When it comes to the total use in the livestock sector, China 
is by far the largest user, followed by the United States and Brazil 
according to the recent estimates (Van Boeckel et  al., 2017). 
Notably, these countries are all very large livestock producers. 
Also, they do have substantial populations of intensive farmed 
pig and poultry, which are the livestock systems where most of 
the antibiotics are used.
The use of antibiotics for prevention and as growth promotors 
are most prevalent in pig and poultry rearing but may be avoided 
by instead applying adequate preventive measures (Magnusson 
et al., 2019). On the regulatory side, Sweden was the first country 
in the world to ban the use of antibiotics as growth promotors 
in 1986, the entire EU followed in 2006, and the United States in 
2017. Still, OIE reports that 45 countries, out of the 155 providing 
data to their annual reports on antimicrobials, allow the use of 
antibiotics for growth promotion (OIE, 2018b). A global ban on 
the use of antibiotics for growth promotion seems, therefore, 
justified.
The wide-spread regular, preventive use of antibiotics in 
some livestock systems may be phased out by applying other 
disease preventive measures as discussed in the following 
section. Another challenge is the medically irrational and 
arbitrary use, often seen in the settings with weak animal 
health service (Ström et al., 2018). In these cases, there is a call 
for a more medically rational use of antibiotics as outlined in 
Magnusson et al., 2019: 1)  just use quality-assured medicines; 
2)  do not use antimicrobials as growth promotors and avoid 
regular preventive use of antibiotics; 3)  avoid using Highest 
Priority Critically Important Antibiotics for human medicine 
in livestock; 4)  only use antibiotics based on a diagnosis of 
the disease by an animal health professional and only for 
authorized indications; and 5)  strive for individual treatment 
of animals with the correct dose and duration, and avoid using 
antimicrobials for group treatments, especially via feed. Also 
when possible, the selection of antibiotics for therapeutic use 
may be based on sensitivity testing. Such a medically rational 
use will in several settings improve animal health and reduce 




PCU population correction unit
Table 1. Antimicrobial prescriptions required in animals, percentages 
by income group. Data from 70 non-EU countries (EC, 2017) 
World Bank income 
group 
Yes, in all 
cases, %
Yes, some 
cases, % No, %
No. of 
countries
High income 42 42 16 12
Upper middle income 48 26 26 11
Lower middle income 20 45 35 20







ent_1/S4/5894002 by guest on 21 January 2021
S6 | Journal of Animal Science, 2020, Vol. 98, No. Suppl. 1
Reduction of Antibiotic Use and Productivity
Northern European countries have a very low use of antibiotics 
per livestock biomass compared with other OECD-countries 
(e.g., ESVAC, 2019). Reducing the use of antibiotics to those 
levels in other parts of the world without implementing 
disease-preventing measures would, of course, be detrimental 
for animal health and productivity. The change in antibiotic 
use must be tightly matched with improved animal health 
management in a stepwise manner over time. If properly 
implemented, this transition will maintain the animal health 
status and productivity, with a limited and transient reduction 
in profit for the producers (Wierup, 2001). Actually, in Sweden 
that banned antibiotics as feed additives in 1986 with limited 
new preventive measures in place, the use of antibiotics initially 
increased (Figure 2; Swedres-Svarm, 2018). This was attributable 
to an increased need of antibiotics for curing an increased 
disease incidence before appropriate preventive measures were 
in place. However, nowadays, the productivity per dairy cow 
and sow in Sweden are in pair with the highest in the world; 
26.7 weaned piglets per year per sow (weaning age 32 d) and 
10,493 kg Energy Corrected Milk per year per Swedish Holstein 
Cow (Swedish WinPig, 2019; Växa, 2019). 
The following basic principles would reduce the need of 
antibiotics and often increase animal health and productivity 
(Magnusson et  al., 2019): 1)  the basis is the rearing of robust 
animals by providing sufficient and good quality feed and water 
in adequate facilities, 2)  second to apply good external and 
internal biosecurity measures to prevent infections from entering 
the farm and spread within the farm (Davies and Wales, 2019), 
Figure 1. Sales for food-producing species, in mg per population correction unit (mg/PCU), of the various veterinary antimicrobial classes, for 31 European countries, 
in 2017 (ESVAC, 2019).
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and 3) finally applying relevant vaccination schemes for specific 
diseases (Hoelzer et al., 2018). In many settings, this requires a 
new skill set for veterinarians: to move from only diagnosing 
and curing, toward more infection epidemiology thinking, 
knowledge about vaccine schemes, and a general herd 
management. 
Besides acquiring these animal health management skills 
and applying a medically rational use of antibiotics, a supportive 
policy environment will enhance the transition toward prudent 
and effective use of antibiotics. For instance, the access of 
antibiotics over-the-counter for layman should be banned; 
antibiotics should only be sold on prescription. Another issue is 
the lack of proper quality control of animal medicines in general 
and antibiotics in particular; regulations or such control must 
be enforced. Also, another regulatory mean that may contribute 
to the restrictive use of antibiotics is to state the withdrawal 
periods after antibiotic treatment where meat, milk, or egg is 
not allowed for human consumption. Notably, to enforce such 
a regulation, efficient monitoring programs must be in place 
along the food chain to check the compliance and there must be 
corrective measures.
Conclusions
The importance of the resistance in bacteria in the livestock 
sector for the overall resistance emergence in the human 
population is not fully elucidated. Still, it is wise to try to 
mitigate the resistance in the livestock sector. This is best done 
by combining sound policies and regulations with appliance of 
a prudent and medically rational use of antibiotics in the sector. 
However, this approach requires a matching by good disease 
preventive measures, based on good animal management that 
generates robust and disease-resistant animals, high biosecurity, 
and effective vaccination programs. Experience from Sweden 
and other Nordic countries show that good health and high 
productivity may be maintained. However, the approach does 
require, in several settings, new skills and mindsets among 
producers, animal health professionals, and other extension 
personnel.
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